Valuation: Becton, Dickinson and Company

Market Cap 52.3B 44.8B 41.92B 38.37B 72.01B 5,004B 72.96B 495B 193B 2,514B 196B 192B 8,314B P/E 2026 *
37x
P/E 2027 * 20.6x
Enterprise Value 68.18B 58.41B 54.65B 50.02B 93.88B 6,524B 95.12B 646B 252B 3,277B 256B 250B 10,839B EV / Sales 2026 *
3.53x
EV / Sales 2027 * 3.36x
Free-Float
73.18%
Yield 2026 *
2.04%
Yield 2027 * 2.08%
1 day+2.90%
1 week+3.42%
Current month+14.71%
1 month+21.49%
3 months+30.82%
6 months+7.11%
Current year-1.48%
1 week 152.5
Extreme 152.5
163.4
1 month 135.2
Extreme 135.2
163.4
Current year 122.3
Extreme 122.3
180.9
1 year 122.3
Extreme 122.3
180.9
3 years 122.3
Extreme 122.3
260.5
5 years 122.3
Extreme 122.3
263.5
10 years 122.3
Extreme 122.3
263.5
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+2.90%+3.42% - - 52.3B
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +1.53%+0.28%+9.51%+16.66% 66.7B
Weighted average by Cap. +1.64%+1.90%+1.97%+17.88%

Financials

2026 *2027 *
Net sales 19.29B 16.52B 15.46B 14.15B 26.56B 1,846B 26.91B 183B 71.24B 927B 72.44B 70.86B 3,067B 19.73B 16.9B 15.82B 14.48B 27.17B 1,888B 27.53B 187B 72.87B 948B 74.1B 72.48B 3,137B
Net income 1.44B 1.23B 1.15B 1.05B 1.98B 137B 2B 13.6B 5.31B 69.05B 5.39B 5.28B 228B 2.34B 2B 1.88B 1.72B 3.22B 224B 3.26B 22.15B 8.64B 112B 8.78B 8.59B 372B
Net Debt 15.88B 13.61B 12.73B 11.65B 21.87B 1,520B 22.16B 150B 58.66B 763B 59.65B 58.35B 2,525B 13.95B 11.95B 11.18B 10.24B 19.21B 1,335B 19.46B 132B 51.52B 671B 52.39B 51.25B 2,218B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
21/08/26 €164.45 +0.64%
20/08/26 €163.40 +2.90%
19/08/26 €158.80 +2.22%
18/08/26 €155.35 -1.89%
17/08/26 €158.35 +0.22%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
192.00USD
Average target price
194.42USD
Spread / Average Target
+1.26%

Quarterly revenue - Rate of surprise